Having found that the effectiveness of some common type 2 diabetes medications may depend upon an individual’s genetic make-up, researchers at the University of Dundee’s School of Medicine have identified two genes that could impact upon how GLP-1 receptor agonists - medication used to treat the condition - work. Click to read more.